Clinical Trial Update: Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Furocyst for Polycystic Ovary Syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Furocyst (furocyst)

Snippet

Sponsor: Chemical Resources | Conditions: Poly Cystic Ovary Syndrome | Phase 4 | Status: COMPLETED